Analyst firms · Argus Research · ELV

Argus Research ELV price target and rating history

Elevance Health Inc. (ELV) · Health Care

Argus Research rates Elevance Health Inc. (ELV) Hold with a $450 price target, as of its latest action on Jul 21, 2025. It has published 3 rating actions on ELV since October 2024, including 1 upgrade and 2 downgrades. Across 5 firms with a ELV price target in the last 12 months, the median target is $425.

Current rating
Hold
Price target
$450
Median target, all firms
$425
Actions on ELV
3

Every Argus Research rating on ELV

How other firms rate ELV

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Deutsche BankBuy$498May 20, 2026
BofA SecuritiesBuy$435Apr 29, 2026
Evercore ISIIn-line$345Apr 8, 2026
RBC Capital MarketsSector Perform$358Feb 3, 2026
Wolfe ResearchOutperform$425Jan 8, 2026

Questions about Argus Research and ELV

What is Argus Research's price target for ELV?
Argus Research's latest stated price target for Elevance Health Inc. (ELV) is $450, from its action on Mar 17, 2025.
What is Argus Research's rating on ELV?
Argus Research rates ELV Hold, a neutral rating, as of Jul 21, 2025.
When did Argus Research last change its view on ELV?
On Jul 21, 2025, Argus Research downgrades to Hold from Buy.
How does Argus Research's ELV target compare with other analysts?
Across 5 firms with a ELV price target in the last 12 months, the median target is $425.

More ELV rating histories

All Argus Research ratingsELV news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.